Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	benzoate-CoA ligase activity	ACSM2A ACSM2B	1.38e-04	3	136	2	GO:0018858
GeneOntologyMolecularFunction	mannosidase activity	MAN2B2 MANBA EDEM1	1.62e-04	16	136	3	GO:0015923
GeneOntologyMolecularFunction	decanoate-CoA ligase activity	ACSM2A ACSM2B	2.74e-04	4	136	2	GO:0102391
GeneOntologyBiologicalProcess	transposable element silencing	TDRD5 ZNF93 APOBEC3G APOBEC3F MYBL1	1.23e-05	46	135	5	GO:0010526
GeneOntologyBiologicalProcess	retrotransposition	TDRD5 ZNF93 APOBEC3G APOBEC3F MYBL1	1.52e-05	48	135	5	GO:0032197
GeneOntologyBiologicalProcess	transposition	TDRD5 ZNF93 APOBEC3G APOBEC3F MYBL1	1.86e-05	50	135	5	GO:0032196
GeneOntologyBiologicalProcess	regulation of microtubule-based process	SEMG2 LAMP1 CHMP7 PRKAA1 CCNL1 RBM14 KLHL42 TAC1 SKA1 DNAH11	2.37e-05	293	135	10	GO:0032886
GeneOntologyBiologicalProcess	regulation of cytoskeleton organization	WASHC4 NEB ARHGEF15 CHMP7 PTK2B CYRIA LATS1 PRKAA1 RBM14 TENM1 TAC1 SSH2 ARHGAP18 SKA1	2.73e-05	579	135	14	GO:0051493
GeneOntologyBiologicalProcess	organelle assembly	MYH6 MYH7 LRFN1 DHX37 SPEF2 TBC1D7 AMBRA1 ODF2 NEB CHMP7 PTK2B NCOR1 CELSR3 MRPS2 PRKAA1 RBM14 ASPM PCDH15 BIN2 ATM	5.12e-05	1138	135	20	GO:0070925
GeneOntologyBiologicalProcess	mucociliary clearance	NEK10 SPEF2 VANGL1	7.47e-05	13	135	3	GO:0120197
Domain	TUDOR	TDRD5 KDM4C RNF17 ALG13	2.08e-05	23	135	4	PS50304
Domain	Tudor	TDRD5 KDM4C RNF17 ALG13	6.18e-05	30	135	4	IPR002999
Pubmed	Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death.	UBR4 AMBRA1 RPTOR PRKAA1 SNX8	2.86e-06	56	137	5	27103069
Pubmed	Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein.	APOBEC3G APOBEC3F ATM	3.30e-06	8	137	3	23202519
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	STARD13 MYH6 MYH7 DENND4A DDX17 SPEF2 UBR4 ODF2 NEB RNF17 PALB2 NFE2L3 NCOR1 LATS1 CEBPZ ASPM TENM1 ATM TOP3B	4.06e-06	1442	137	19	35575683
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	STARD13 DDX17 WASHC4 DHX37 IARS1 UBR4 CASP8 AMBRA1 NKRF DHX15 POLR3B CEBPZ RPTOR PI4KA EIF3L RBM14 ASPM BUB3	6.53e-06	1353	137	18	29467282
Pubmed	Suppression of atrial myosin gene expression occurs independently in the left and right ventricles of the developing mouse heart.	MYH6 MYH7 DNAH11	7.03e-06	10	137	3	10679931
Pubmed	ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection.	DDX17 APOBEC3G AMBRA1 NKRF APOBEC3F DHX15 NCOR1 SLC35A4 RBM14	7.99e-06	336	137	9	31253590
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	MYH7 LRFN1 DDX17 DHX37 IARS1 LAMP1 RNF17 ARHGEF15 DHX15 ARFGAP2 PI4KA ABCD1 BUB3	9.59e-06	754	137	13	35906200
Pubmed	Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly.	TELO2 RPTOR ATM	9.64e-06	11	137	3	20427287
Pubmed	Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice.	MYH6 MYH7 PTK2B	9.64e-06	11	137	3	16374517
Pubmed	Reversible epigenetic modifications of the two cardiac myosin heavy chain genes during changes in expression.	MYH6 MYH7	1.54e-05	2	137	2	21526716
Pubmed	Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	17428847
Pubmed	Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	26482266
Pubmed	Variants near CCNL1/LEKR1 and in ADCY5 and fetal growth characteristics in different trimesters.	ADCY5 CCNL1	1.54e-05	2	137	2	21307140
Pubmed	Dual-functional significance of ATM-mediated phosphorylation of spindle assembly checkpoint component Bub3 in mitosis and the DNA damage response.	ATM BUB3	1.54e-05	2	137	2	35085551
Pubmed	Status of APOBEC3G/F in cells and progeny virions modulated by Vif determines HIV-1 infectivity.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	19944180
Pubmed	Dispersed sites of HIV Vif-dependent polyubiquitination in the DNA deaminase APOBEC3F.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	23318957
Pubmed	Different interaction between HIV-1 Vif and its cellular target proteins APOBEC3G/APOBEC3F.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	20299747
Pubmed	Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	17522216
Pubmed	Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	18619467
Pubmed	Remarkable lethal G-to-A mutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	20610708
Pubmed	Knockdown of AMPKα decreases ATM expression and increases radiosensitivity under hypoxia and nutrient starvation in an SV40-transformed human fibroblast cell line, LM217.	PRKAA1 ATM	1.54e-05	2	137	2	29284117
Pubmed	Interactions in vivo between the Vif protein of HIV-1 and the precursor (Pr55(GAG)) of the virion nucleocapsid proteins.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	19826902
Pubmed	The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	15647250
Pubmed	Characterization of human cardiac myosin heavy chain genes.	MYH6 MYH7	1.54e-05	2	137	2	2726733
Pubmed	Activation of AMP-activated protein kinase in cerebella of Atm-/- mice is attributable to accumulation of reactive oxygen species.	PRKAA1 ATM	1.54e-05	2	137	2	22260947
Pubmed	Growth regulation by estrogen in breast cancer 1 (GREB1) is a novel progesterone-responsive gene required for human endometrial stromal decidualization.	PGR GREB1	1.54e-05	2	137	2	28911214
Pubmed	Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	16501124
Pubmed	Human cardiac myosin heavy chain genes and their linkage in the genome.	MYH6 MYH7	1.54e-05	2	137	2	3037493
Pubmed	β-myosin heavy chain is induced by pressure overload in a minor subpopulation of smaller mouse cardiac myocytes.	MYH6 MYH7	1.54e-05	2	137	2	21778428
Pubmed	Structural organization of the human cardiac alpha-myosin heavy chain gene (MYH6).	MYH6 MYH7	1.54e-05	2	137	2	8307559
Pubmed	HIV-1 Vif: counteracting innate antiretroviral defenses.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	14565218
Pubmed	Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	18367521
Pubmed	Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	19669862
Pubmed	Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	25590131
Pubmed	Identification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	19535447
Pubmed	Nuclear DNA damage-triggered ATM-dependent AMPK activation regulates the mitochondrial radiation response.	PRKAA1 ATM	1.54e-05	2	137	2	38166485
Pubmed	Comparative analysis of the gene-inactivating potential of retroviral restriction factors APOBEC3F and APOBEC3G.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	26048885
Pubmed	Identification of two APOBEC3F splice variants displaying HIV-1 antiviral activity and contrasting sensitivity to Vif.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	20624919
Pubmed	[Effect of papillary thyroid carcinoma related gene PTC1 on subcellular localization and function of ATM cell].	PTCH1 ATM	1.54e-05	2	137	2	15142440
Pubmed	Molecular cloning and characterization of human cardiac alpha- and beta-form myosin heavy chain complementary DNA clones. Regulation of expression during development and pressure overload in human atrium.	MYH6 MYH7	1.54e-05	2	137	2	2969919
Pubmed	Comparative analyses of disease risk genes belonging to the acyl-CoA synthetase medium-chain (ACSM) family in human liver and cell lines.	ACSM2A ACSM2B	1.54e-05	2	137	2	19634011
Pubmed	Distribution and structure-function relationship of myosin heavy chain isoforms in the adult mouse heart.	MYH6 MYH7	1.54e-05	2	137	2	17575272
Pubmed	Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene.	MYH6 MYH7	1.54e-05	2	137	2	9884344
Pubmed	RNA and DNA binding properties of HIV-1 Vif protein: a fluorescence study.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	17609216
Pubmed	Role of microtubules versus myosin heavy chain isoforms in contractile dysfunction of hypertrophied murine cardiocytes.	MYH6 MYH7	1.54e-05	2	137	2	12750067
Pubmed	Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	19036809
Pubmed	Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	19587057
Pubmed	Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	17142455
Pubmed	A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	15152192
Pubmed	Human APOBEC3F incorporation into human immunodeficiency virus type 1 particles.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	25038404
Pubmed	Transgenic mouse α- and β-cardiac myosins containing the R403Q mutation show isoform-dependent transient kinetic differences.	MYH6 MYH7	1.54e-05	2	137	2	23580644
Pubmed	Structural determinants of HIV-1 Vif susceptibility and DNA binding in APOBEC3F.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	24185281
Pubmed	Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	20335268
Pubmed	Structural basis for DEAH-helicase activation by G-patch proteins.	NKRF DHX15	1.54e-05	2	137	2	32179686
Pubmed	Positioning of APOBEC3G/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8+ T cells.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	24722422
Pubmed	β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations.	MYH6 MYH7	1.54e-05	2	137	2	24829265
Pubmed	Inhibition of LINE-1 and Alu retrotransposition by exosomes encapsidating APOBEC3G and APOBEC3F.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	20153011
Pubmed	Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart.	MYH6 MYH7	1.54e-05	2	137	2	2036722
Pubmed	Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	27881650
Pubmed	Ensemble force changes that result from human cardiac myosin mutations and a small-molecule effector.	MYH6 MYH7	1.54e-05	2	137	2	25937279
Pubmed	APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	17145955
Pubmed	Repression of porcine endogenous retrovirus infection by human APOBEC3 proteins.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	21396348
Pubmed	A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	15054139
Pubmed	Inhibition of hepatitis B virus replication by APOBEC3G.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	15031497
Pubmed	Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	24503066
Pubmed	Myocardial contraction is 5-fold more economical in ventricular than in atrial human tissue.	MYH6 MYH7	1.54e-05	2	137	2	15621050
Pubmed	APOBEC3 proteins and reverse transcription.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	18262674
Pubmed	Different mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanisms.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	24651717
Pubmed	Death and the retrovirus.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	14557052
Pubmed	Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	20686027
Pubmed	The L513S polymorphism in medium-chain acyl-CoA synthetase 2 (MACS2) is associated with risk factors of the metabolic syndrome in a Caucasian study population.	ACSM2A ACSM2B	1.54e-05	2	137	2	16521160
Pubmed	Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone.	MYH6 MYH7	1.54e-05	2	137	2	18480046
Pubmed	High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	25985400
Pubmed	APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	17121840
Pubmed	Murine pulmonary myocardium: developmental analysis of cardiac gene expression.	MYH6 MYH7	1.54e-05	2	137	2	7919499
Pubmed	Quantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	24623435
Pubmed	E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	22695298
Pubmed	Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	19169351
Pubmed	Long-Read Sequence Confirmed a Large Deletion Including MYH6 and MYH7 in an Infant of Atrial Septal Defect and Atrial Arrhythmias.	MYH6 MYH7	1.54e-05	2	137	2	34384224
Pubmed	APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	20219927
Pubmed	The protein family of RNA helicases.	DDX17 DHX15	1.54e-05	2	137	2	9747670
Pubmed	Human cardiac myosin heavy chain gene mapped within chromosome region 14q11.2----q13.	MYH6 MYH7	1.54e-05	2	137	2	2494889
Pubmed	Moderate influence of human APOBEC3F on HIV-1 replication in primary lymphocytes.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	20592068
Pubmed	Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	17459442
Pubmed	Absence of birth-weight lowering effect of ADCY5 and near CCNL, but association of impaired glucose-insulin homeostasis with ADCY5 in Asian Indians.	ADCY5 CCNL1	1.54e-05	2	137	2	21712988
Pubmed	The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo.	RPTOR PRKAA1	1.54e-05	2	137	2	25607458
Pubmed	Differential sensitivity of porcine endogenous retrovirus to APOBEC3-mediated inhibition.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	26016442
Pubmed	The HIV-1 central polypurine tract functions as a second line of defense against APOBEC3G/F.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	20844042
Pubmed	All-atom molecular dynamics simulations of actin-myosin interactions: a comparative study of cardiac α myosin, β myosin, and fast skeletal muscle myosin.	MYH6 MYH7	1.54e-05	2	137	2	24224850
Pubmed	Myosin heavy chain composition and the economy of contraction in healthy and diseased human myocardium.	MYH6 MYH7	1.54e-05	2	137	2	16088376
Pubmed	Molecular docking analysis of RN18 and VEC5 in A3G-Vif inhibition.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	25489169
Pubmed	Complete sequence of human cardiac alpha-myosin heavy chain gene and amino acid comparison to other myosins based on structural and functional differences.	MYH6 MYH7	1.54e-05	2	137	2	1776652
Pubmed	Stably expressed APOBEC3F has negligible antiviral activity.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	20702622
Pubmed	Exome sequencing identifies nonsegregating nonsense ATM and PALB2 variants in familial pancreatic cancer.	PALB2 ATM	1.54e-05	2	137	2	23561644
Pubmed	T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaques.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	23536679
Pubmed	Unusual substitutions in HIV-1 vif from children infected perinatally without progression to AIDS for more than 8 years without therapy.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	23080486
Pubmed	Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.	MYH6 MYH7	1.54e-05	2	137	2	9541509
Pubmed	Loss of AMP-activated protein kinase induces mitochondrial dysfunction and proinflammatory response in unstimulated Abcd1-knockout mice mixed glial cells.	PRKAA1 ABCD1	1.54e-05	2	137	2	25861159
Pubmed	Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	19487726
Pubmed	APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.	APOBEC3G APOBEC3F	1.54e-05	2	137	2	16641889
Cytoband	11q22-q23	PGR ATM	1.32e-04	6	137	2	11q22-q23
Cytoband	12q24.33	ZNF268 ZNF891 GALNT9	4.08e-04	48	137	3	12q24.33
Cytoband	Ensembl 112 genes in cytogenetic band chr22q13	DDX17 EFCAB6 APOBEC3G PKDREJ APOBEC3F EIF3L	4.92e-04	330	137	6	chr22q13
GeneFamily	Tudor domain containing	TDRD5 KDM4C RNF17 ALG13	4.49e-05	37	97	4	780
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DDX17 KDM4C CASP8 SLC9A4 CCNL1 TENM1 ATM MYBL1	1.81e-07	197	137	8	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DDX17 NEK10 SPEF2 CASP8 PTCH1 TENM1 ATM MYBL1	1.81e-07	197	137	8	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	EFCAB6 NEK10 SPEF2 TSGA10 FGF14 ARHGAP18 DNAH11	2.30e-06	193	137	7	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ZBTB38 DDX60 APOBEC3G SAMD9L ATM BUB3 MYBL1	2.30e-06	193	137	7	fce4f805e53669acb4c188f87ac7d84408c0c218
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ZBTB38 DDX60 APOBEC3G SAMD9L ATM BUB3 MYBL1	2.30e-06	193	137	7	6e1498153a7766c03fddbda1701dbf1596d21736
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZBTB38 APOBEC3G C5orf34 SAMD9L TENM1 BIN2 MYBL1	2.55e-06	196	137	7	17f17edadafdad9f24e88d708d7e1c765503131c
ToppCell	mild-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZBTB38 DDX60 APOBEC3G CASP8 SAMD9L ATM MYBL1	2.91e-06	200	137	7	d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZBTB38 APOBEC3G PTCH1 SAMD9L CEBPZ ATM MYBL1	2.91e-06	200	137	7	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STARD13 TLR8 RGS18 PTPRK GALNT9 C3	7.98e-06	153	137	6	0ef7c45cdd854c79e527006034029767f8e108b2
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	APOBEC3G GRM6 APOBEC3F TMEM143 ST18 ZNF426	1.03e-05	160	137	6	8374ae912337947b2cc8d17d5840f306361fe1ff
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TDRD5 NEB PCDH15 TENM1 ST18 ACSM2B	1.11e-05	162	137	6	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	APOBEC3G GRIK4 CELSR3 ASPM BIN2 MYBL1	1.19e-05	164	137	6	649e42d9cfdec2f7771d1e938b516e46e7d07078
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	APOBEC3G GRIK4 CELSR3 ASPM BIN2 MYBL1	1.19e-05	164	137	6	ba85f7b21ae34e285d286ada24715885ca6329f7
ToppCell	356C-Lymphocytic-ILC-ILC-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	BCKDHA ZFP69 RGS18 RPTOR ZNF81 ACSM2B	1.50e-05	171	137	6	3d26ef58fe5231373d7df9ac79d225546918cf82
ToppCell	CV-Mild-7\|Mild / Virus stimulation, Condition and Cluster	DDX17 WASHC4 ZNF268 IARS1 ZNF891 ZNF81	1.61e-05	173	137	6	c9bbca9313a0fdf146c8c995624b94b937e818d8
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	APOBEC3G CASP8 PTCH1 BIN2 ATM MYBL1	1.61e-05	173	137	6	36a471576a9d2325066bb14c2f2cd89c67b92915
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BCKDHA POLR3B BIN2 ATM ZNF426 MYBL1	1.61e-05	173	137	6	79d11f94a8f6a420c18c2fef0da77e9af3204765
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDX60 CYRIA SAMD9L C3 SSH2 TMCC1	1.71e-05	175	137	6	cf53a15bfb37b6019e7052ffdf594a9ac040900e
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KIAA1217 ASPM PCDH15 TENM1 TAC1 GREB1	1.95e-05	179	137	6	d1365d48d1b017a7917f4f63a82ac4720c3d87df
ToppCell	ASK440-Immune-NK_cell\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	APOBEC3G CASP8 PKDREJ BIN2 BUB3 MYBL1	2.01e-05	180	137	6	340e750356d23fe9af0e8f298f8a273ff426052f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB6 NEB PCDH15 TENM1 ST18 DNAH11	2.27e-05	184	137	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB6 NEB PCDH15 TENM1 ST18 DNAH11	2.27e-05	184	137	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB6 NEB PCDH15 TENM1 ST18 DNAH11	2.27e-05	184	137	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_A2\|390C / Donor, Lineage, Cell class and subclass (all cells)	AMBRA1 PALB2 NFE2L3 RPTOR ABCD1	2.41e-05	111	137	5	dfbdeadad321392d359e6fb7112b28b043a4b874
ToppCell	COVID-19_Severe-Lymphoid_T/NK-CD8+_T_activated\|COVID-19_Severe / Disease group, lineage and cell class	ZBTB38 DDX60 APOBEC3G RNF17 SAMD9L MYBL1	2.49e-05	187	137	6	4c4c4406e16a15dedcd50bbcc2059d722a2e3d2c
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KIAA1217 ASPM PCDH15 TENM1 TAC1 GREB1	2.57e-05	188	137	6	8de5a07301f9b5984680c873e5a92395b5ed3dd3
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ZBTB38 DDX60 APOBEC3G RNF17 SAMD9L MYBL1	2.72e-05	190	137	6	b9182c84e44aa31684b5388cf3ef4fd1b9e51de4
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZBTB38 DDX60 APOBEC3G RNF17 SAMD9L MYBL1	2.72e-05	190	137	6	88c092a5e78ccaddf406f8fff74376bb761b9790
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ZBTB38 DDX60 APOBEC3G RNF17 SAMD9L MYBL1	2.72e-05	190	137	6	4b42a16902d7d1494f953cc88af1e761e76bdf2c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZBTB38 DDX60 APOBEC3G RNF17 SAMD9L MYBL1	2.72e-05	190	137	6	9501f0995f3d52be90c02b1aa0c7d184bd788c16
ToppCell	E17.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PLVAP ARHGEF15 ASPM ARHGAP18 BUB3 SKA1	2.80e-05	191	137	6	efe0cb0b6602621f5eda72a723b83b38bf15607f
ToppCell	E17.5-Endothelial-proliferative_endothelial_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PLVAP ARHGEF15 ASPM ARHGAP18 BUB3 SKA1	2.80e-05	191	137	6	00676c598f6dae0ff9158d064248f1265432f3e1
ToppCell	LPS_only-Unknown-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRFN1 GRIK4 ADCY5 TLR8 GALNT9	2.85e-05	115	137	5	ad5298c2ad8bf94fa13c2e50b0799e929473ef59
ToppCell	LPS_only-Unknown\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRFN1 GRIK4 ADCY5 TLR8 GALNT9	2.85e-05	115	137	5	7a733f6987b40ec497a03734b79ed5355ad3a2fc
ToppCell	LPS_only-Unknown-Endothelial-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRFN1 GRIK4 ADCY5 TLR8 GALNT9	2.85e-05	115	137	5	c67145d3cd9243994a141749b426ff2a6dcc8d93
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND4A MANBA KDM4C AMBRA1 CYRIA SSH2	2.97e-05	193	137	6	779276e775cb2492e8dd36436295a536084a6415
ToppCell	3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLVAP GIMAP2 ARHGEF15 ASPM ACSM2A ACSM2B	2.97e-05	193	137	6	1b69f92c6a7a2516e393d3f3c371407ec791343d
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPEF2 GRIK4 ARHGEF15 PTPRK KIAA1217 ARHGAP18	3.06e-05	194	137	6	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SYNE3 KIAA1217 PCDH15 TENM1 TAC1 GREB1	3.06e-05	194	137	6	e5990880961d2469759ce4b3b20ae93ace3ebd1f
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	NEK10 SPEF2 PTPRK KIAA1217 FGF14 DNAH11	3.15e-05	195	137	6	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TLR8 PTK2B CYRIA RGS18 BIN2 SSH2	3.15e-05	195	137	6	1d58585557bf8e9ce4d514e128d3a902b526331d
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	NEK10 SPEF2 PTPRK KIAA1217 FGF14 DNAH11	3.15e-05	195	137	6	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	NEK10 SPEF2 PTPRK KIAA1217 FGF14 DNAH11	3.15e-05	195	137	6	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ZBTB38 APOBEC3G CASP8 BIN2 ATM BUB3	3.33e-05	197	137	6	2e9677b4b9a7c88db16416e5f114a2031ec3bc24
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ZBTB38 APOBEC3G CASP8 BIN2 ATM BUB3	3.33e-05	197	137	6	4c9919914079e76b1d2220b249e0d0b0d9bf4bc0
ToppCell	mLN-B_cell-B_cell_cycling\|B_cell / Region, Cell class and subclass	NEB POLR3B KIAA1217 ASPM KIAA1958 MYBL1	3.33e-05	197	137	6	2071526fe46de8359ea118ff78581eb4454aa55a
ToppCell	Severe-CD8+_T_activated\|Severe / Disease group and Cell class	GIMAP2 DDX60 APOBEC3G CTSA PTK2B SAMD9L	3.33e-05	197	137	6	bb1e3e1d841c2c7141eb1099e7755860b168b6fc
ToppCell	COVID-19_Moderate-CD8+_T_activated\|COVID-19_Moderate / disease group, cell group and cell class	DDX60 APOBEC3G RNF17 SAMD9L BIN2 MYBL1	3.33e-05	197	137	6	4711ecb157e907758a5021248ae8b043d17672c6
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	DENND4A ZBTB38 TLR8 CYRIA RGS18 C3	3.43e-05	198	137	6	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DDX60 APOBEC3G GRIK4 SAMD9L ATM MYBL1	3.43e-05	198	137	6	0e918e9db9b884f5328d438e90efe065e27266ee
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	DENND4A ZBTB38 TLR8 CYRIA RGS18 C3	3.43e-05	198	137	6	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DDX60 APOBEC3G GRIK4 SAMD9L ATM MYBL1	3.43e-05	198	137	6	ce92d5fbc2eac27fb246b044fb1914ab92506275
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	DDX60 APOBEC3G GRIK4 SAMD9L ATM MYBL1	3.43e-05	198	137	6	fed823d6e684d113bcc9ff3cd1803bb001aa02fa
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	DENND4A ZBTB38 TLR8 CYRIA RGS18 C3	3.43e-05	198	137	6	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DDX60 APOBEC3G GRIK4 SAMD9L ATM MYBL1	3.43e-05	198	137	6	1ef3a6bd681c223eed58300348adfef89df5563c
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DDX17 CASP8 CCNL1 TENM1 ATM MYBL1	3.53e-05	199	137	6	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	COVID-19_Severe-Lymphoid_T/NK-NK_activated\|COVID-19_Severe / Disease group, lineage and cell class	DDX60 APOBEC3G GRIK4 SAMD9L ATM MYBL1	3.53e-05	199	137	6	edf5f80b4c299e6bf462675f2cd3329d86c923d8
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD8-positive,_alpha-beta_T_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CASP8 PTCH1 BIN2 ATM BUB3 MYBL1	3.53e-05	199	137	6	db05c16d80f5a74bfa048a5c92917d312d26f769
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	STARD13 APOBEC3G NEB APOBEC3F C3 ZNF81	3.63e-05	200	137	6	25f4c051c2e869481f33c22ad54de97efac444ad
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DDX17 DDX60 CASP8 SAMD9L CCNL1 ATM	3.63e-05	200	137	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	STARD13 APOBEC3G NEB APOBEC3F C3 ZNF81	3.63e-05	200	137	6	da45a85a4667965b24ba824af871157af5b4cd19
ToppCell	COVID-19_Moderate-B_cell\|World / disease group, cell group and cell class	SLC9A4 PTPRK IGHD GALNT9 GREB1	7.05e-05	139	137	5	b93e1da87d44e55d75e8cc1b87c2970645679c01
ToppCell	Dividing_Macrophages-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	ZNF93 RNF17 C5orf34 ASPM SKA1	9.48e-05	148	137	5	66b51aa6690bf8fbc90fa5a6f86191703e2d5046
ToppCell	P03-Hematopoietic-Immune-immune_cell_unspecified\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TLR8 PTK2B SLC9A4 RGS18 BIN2	9.79e-05	149	137	5	43d756f81d532b5c7f2306e6af9d072d496cbc8e
ToppCell	P03-Hematopoietic-Immune\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TLR8 PTK2B SLC9A4 RGS18 BIN2	9.79e-05	149	137	5	1c5a2572741c47246d455c865e8e1677c9f49598
ToppCell	MS-CD4-CD8_1\|MS / Condition, Cell_class and T cell subcluster	ODF2 P3H4 ABCD1 PNPLA7 TMEM143	1.01e-04	150	137	5	7dc95c58b98d8c4c6c49fb1a03ec6ac24fb41f54
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	STARD13 RGS18 SYNE3 C3 ST18	1.33e-04	159	137	5	2f6c60ddff2208a68146f9786143d9aefd528840
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	STARD13 RGS18 SYNE3 C3 ST18	1.33e-04	159	137	5	ded4e3626a62fb6334403b7213b467fb7e8131c3
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GIMAP2 IARS1 CELSR3 TENM1 MYBL1	1.41e-04	161	137	5	d72c572613f8eff3251cb7b1e9dcc76d193b2f21
ToppCell	droplet-Marrow-BM-30m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UBR4 TLR8 CYRIA GALNT9 KIAA1958	1.45e-04	162	137	5	75df7ff779a3b9159ba97d852da1f8df650b9ce5
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYRIA RGS18 GALNT9 ASPM ST18	1.45e-04	162	137	5	93bd29c52846c3156b8b0d2e39c552373efdfe93
ToppCell	Control-APC-like-Monocytes\|Control / group, cell type (main and fine annotations)	TDRD5 DDX60 APOBEC3G SIPA1 ST18	1.49e-04	163	137	5	4bc80a2c741d462724b6f3902377d48c57478932
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GIMAP2 HLA-G APOBEC3G ANKRD20A3P BIN2	1.58e-04	165	137	5	8dbd03795fff060cd2e4d5d97348f5b63515e030
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GIMAP2 HLA-G APOBEC3G ANKRD20A3P BIN2	1.58e-04	165	137	5	5fc5e34cc805df44c020256729256ef761790152
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GIMAP2 HLA-G APOBEC3G ANKRD20A3P BIN2	1.58e-04	165	137	5	64c7c45383afde1d050934938705e47aa615755f
ToppCell	356C-Endothelial_cells-Endothelial-E\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	HLA-G APOBEC3G CASP8 TELO2 VANGL1	1.76e-04	169	137	5	0425d2580ed325178f522c0093ff4623de6ce7a8
ToppCell	356C-Endothelial_cells-Endothelial-E-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	HLA-G APOBEC3G CASP8 TELO2 VANGL1	1.76e-04	169	137	5	fec669968a77060bd77ee8695034e35a642c984f
ToppCell	CV-Mild-7\|CV / Virus stimulation, Condition and Cluster	WASHC4 ZNF268 IARS1 ZNF891 ZNF81	1.81e-04	170	137	5	25ebde7d2f8ae1afdfaf5876284ff20bb179eb10
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8\|TCGA-Liver / Sample_Type by Project: Shred V9	PLVAP BCKDHA EDEM1 ACSM2A ACSM2B	1.86e-04	171	137	5	c4a919fe3d56ae6df2fcab6686abacc10befc053
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC5A7 GRIK4 PTK2B PTPRK PDZRN4	1.86e-04	171	137	5	fdd96c6fe850bd10e1e0d0f18c4401f8348b7d2c
ToppCell	droplet-Marrow-nan-3m-Myeloid-monocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMP1 CTSA TLR8 CYRIA GALNT9	1.86e-04	171	137	5	992df143d76f9e7fb1997a8996f61e941f0f9d4f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TLR8 PTK2B CYRIA RGS18 BIN2	1.97e-04	173	137	5	0a0127bcb1d7b2b6125faef576dd843055095528
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_A2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	AMBRA1 PALB2 NFE2L3 RPTOR ABCD1	2.08e-04	175	137	5	da191dfb8a7f976a632a3a0b923942ab54f5c8c1
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D7 SLC30A4 PALB2 DNAH11 ALG13	2.13e-04	176	137	5	3766e0533b103ec92ac75eba3df02e287efc53fa
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBC1D7 SLC30A4 PALB2 DNAH11 ALG13	2.13e-04	176	137	5	aa1bada2175d8370fc71939a607407155259d195
ToppCell	Control\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZBTB38 SPEF2 ARHGEF15 KIAA1217 ARHGAP18	2.19e-04	177	137	5	b8ff6940e31b749776e81ae4f5bbd577dba9749c
ToppCell	BAL-Control-cDC_1\|Control / Compartment, Disease Groups and Clusters	DDX60 APOBEC3G RNF17 SAMD9L POLR3B	2.19e-04	177	137	5	aa021f6d62e9d740c5ea499faaf875de835a2865
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KIAA1217 GALNT9 TENM1 PNPLA7 PDZRN4	2.19e-04	177	137	5	bde307e67ad8e48a5ff4c0827015f4688f6b3e46
ToppCell	10x5'-Lung-Lymphocytic_B_plasma-Plasmablasts\|Lung / Manually curated celltypes from each tissue	FOCAD MRPS2 COQ9 ASPM SKA1	2.30e-04	179	137	5	3fa75eec3e86fd1797eaa33362257df7f9b2a0bf
ToppCell	E16.5-samps-Endothelial-Immature_fetal_endothelial-Proliferative_Endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	PLVAP ZFP69 ARHGEF15 ARHGAP18 MYBL1	2.30e-04	179	137	5	d24513a404c9b1d37dd47aa1cdb5713b64b88f89
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTCH1 PALB2 ASPM SKA1 MYBL1	2.30e-04	179	137	5	4166c4e1a8748a79ac6a11fd0b97c5344be2321b
ToppCell	RSV-Healthy-0\|RSV / Virus stimulation, Condition and Cluster	ZBTB38 C5orf34 SAMD9L VANGL1 MYBL1	2.36e-04	180	137	5	974044056e2f7e909cb11c6f6ca89e58bf95f7e5
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GRIK4 KIAA1217 TENM1 PNPLA7 PDZRN4	2.36e-04	180	137	5	b514c55e52b46e8a1a2f09ed2c59a7683367a505
ToppCell	RSV-Healthy-0\|Healthy / Virus stimulation, Condition and Cluster	ZBTB38 C5orf34 SAMD9L VANGL1 MYBL1	2.36e-04	180	137	5	703a1d0f9536af94d56757eb01221878d7b7fe61
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PGR KIAA1217 ASPM TENM1 TAC1	2.43e-04	181	137	5	af92b8b7f455210dab502ef6964f3a0162180759
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	EFCAB6 NEK10 SPEF2 FGF14 DNAH11	2.49e-04	182	137	5	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A\|E18.5-samps / Age Group, Lineage, Cell class and subclass	PLVAP CASP8 ARHGEF15 ARHGAP18 SKA1	2.49e-04	182	137	5	ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KIAA1217 ASPM PCDH15 TENM1 TAC1	2.49e-04	182	137	5	08aff7112c9dac0ef5540300516a604782b21169
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GRIK4 PTK2B PTPRK ARHGAP18 PDZRN4	2.49e-04	182	137	5	31efc06d6b073e8e341648207093e5f33c6f9183
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GRIK4 KIAA1217 ASPM TENM1 PDZRN4	2.49e-04	182	137	5	72e65a23cd36085bc880087d3cae92395de918a1
Disease	microcephaly (implicated_via_orthology)	DHX37 ODF2 ASPM EXOC7	1.21e-05	32	131	4	DOID:10907 (implicated_via_orthology)
Disease	X-21319 measurement	ACSM2A ACSM2B	1.96e-05	2	131	2	EFO_0800807
Disease	X-11478 measurement	ACSM2A ACSM2B	5.85e-05	3	131	2	EFO_0021242
Disease	DNA dC->dU-editing enzyme APOBEC-3G measurement	APOBEC3G APOBEC3F	5.85e-05	3	131	2	EFO_0802473
Disease	autosomal dominant cerebellar ataxia (is_implicated_in)	SAMD9L FGF14	5.85e-05	3	131	2	DOID:1441 (is_implicated_in)
Disease	Medulloblastoma	KDM4C PTCH1 PALB2 ATM	7.29e-05	50	131	4	C0025149
Disease	lymphocyte count	ZBTB38 MANBA SPEF2 TBC1D7 HLA-G CASP8 ADCY5 ARHGEF15 FOCAD NFE2L3 NCOR1 C5orf34 SLC9A4 C3 ABCD1 ATM SSH2 SETD3	8.59e-05	1464	131	18	EFO_0004587
Disease	Cardiomyopathy, Familial Hypertrophic, 1 (disorder)	MYH6 MYH7	1.17e-04	4	131	2	C3495498
Disease	Hypertrophic cardiomyopathy 1	MYH6 MYH7	1.17e-04	4	131	2	cv:C3495498
Disease	Caveolinopathy	MYH6 MYH7	1.17e-04	4	131	2	cv:C5679790
Disease	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH6 MYH7	1.17e-04	4	131	2	192600
Disease	melanoma	KDM4C UBR4 CASP8 SIPA1 PTK2B PTPRK ATM	1.25e-04	248	131	7	C0025202
Disease	3-hydroxyhexanoate measurement	ACSM2A ACSM2B	1.94e-04	5	131	2	EFO_0800378
Disease	Malignant tumor of breast	CASP8 PALB2 ATM	2.31e-04	27	131	3	cv:C0006142
Disease	Breast neoplasm	CASP8 PALB2 ATM	2.31e-04	27	131	3	cv:C1458155
Disease	Familial cancer of breast	CASP8 PALB2 ATM	2.31e-04	27	131	3	cv:C0346153
Disease	monocyte count	DENND4A PLVAP SPEF2 APOBEC3G CASP8 ADCY5 TLR8 CHMP7 PTK2B CYRIA SLC9A4 TELO2 PI4KA C3 ATM SSH2	2.57e-04	1320	131	16	EFO_0005091
Disease	indoleacetoylcarnitine measurement	ACSM2A ACSM2B	2.90e-04	6	131	2	EFO_0800106
Disease	Malignant neoplasm of breast	GABRP UBR4 CASP8 GRM6 PKDREJ PALB2 PGR NCOR1 C5orf34 KCNH1 PRKAA1 TENM1 ATM FASTKD3	3.09e-04	1074	131	14	C0006142
Disease	esophagus squamous cell carcinoma (is_marker_for)	KDM4C CASP8 PTCH1 ATM	3.36e-04	74	131	4	DOID:3748 (is_marker_for)
Disease	Idiopathic hypertrophic subaortic stenosis	MYH6 MYH7	4.05e-04	7	131	2	C0700053
Disease	Obstructive asymmetric septal hypertrophy	MYH6 MYH7	4.05e-04	7	131	2	C0597124
Disease	female breast cancer (is_implicated_in)	PALB2 ATM	5.38e-04	8	131	2	DOID:0050671 (is_implicated_in)
Disease	breast cancer (is_implicated_in)	KDM4C CASP8 PTK2B PRKAA1 ATM	5.65e-04	150	131	5	DOID:1612 (is_implicated_in)
Disease	Cardiomyopathy, Hypertrophic, Familial	MYH6 MYH7	6.90e-04	9	131	2	C0949658
Disease	body height at birth	ZBTB38 PTCH1 ADCY5	7.49e-04	40	131	3	EFO_0006784
Disease	Major Depressive Disorder	SLC5A7 GRIK4 ADCY5 TAC1 RNF41 EDEM1	7.78e-04	243	131	6	C1269683
Disease	Neoplasm of uncertain or unknown behavior of breast	CASP8 PALB2 NCOR1	8.06e-04	41	131	3	C0496956
Disease	Breast adenocarcinoma	CASP8 PALB2 NCOR1	8.06e-04	41	131	3	C0858252
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH6 MYH7	8.60e-04	10	131	2	DOID:0111269 (implicated_via_orthology)
Disease	age at menarche, spine bone mineral density	KCNH1 PCDH15	8.60e-04	10	131	2	EFO_0004703, EFO_0007701
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH6 MYH7	8.60e-04	10	131	2	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH6 MYH7	8.60e-04	10	131	2	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH6 MYH7	8.60e-04	10	131	2	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH6 MYH7	8.60e-04	10	131	2	DOID:0080719 (implicated_via_orthology)
Disease	Muscular dystrophy, limb-girdle, autosomal dominant	MYH6 MYH7	8.60e-04	10	131	2	cv:C5675009
Disease	inclusion body myositis (implicated_via_orthology)	MYH6 MYH7	8.60e-04	10	131	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH6 MYH7	8.60e-04	10	131	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH6 MYH7	8.60e-04	10	131	2	DOID:0080326 (implicated_via_orthology)
Disease	status epilepticus (biomarker_via_orthology)	CASP8 PTK2B ATM CKMT1A	1.05e-03	100	131	4	DOID:1824 (biomarker_via_orthology)
Disease	unipolar depression, information processing speed, cognitive function measurement	GRIK4 GRM6 PCDH15	1.20e-03	47	131	3	EFO_0003761, EFO_0004363, EFO_0008354
Disease	distal myopathy (implicated_via_orthology)	MYH6 MYH7	1.25e-03	12	131	2	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH6 MYH7	1.25e-03	12	131	2	DOID:2106 (implicated_via_orthology)
Disease	Cardiomyopathy, Dilated	MYH6 MYH7 ATM	1.28e-03	48	131	3	C0007193
Disease	Cardiomyopathy, Familial Idiopathic	MYH6 MYH7 ATM	1.44e-03	50	131	3	C1449563
Disease	Fibrosis	ADCY5 TAC1 ATM	1.44e-03	50	131	3	C0016059
Disease	Cirrhosis	ADCY5 TAC1 ATM	1.44e-03	50	131	3	C1623038
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH6 MYH7	1.48e-03	13	131	2	DOID:397 (implicated_via_orthology)
Disease	monocyte percentage of leukocytes	DENND4A PLVAP MANBA SPEF2 ADCY5 NFE2L3 CHMP7 PI4KA C3 SSH2	1.61e-03	731	131	10	EFO_0007989
Disease	Huntington's disease (is_marker_for)	CASP8 NCOR1 SYNE3	1.70e-03	53	131	3	DOID:12858 (is_marker_for)
Disease	chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology)	PI4KAP2 PI4KA	1.72e-03	14	131	2	DOID:0060413 (implicated_via_orthology)
Disease	plasminogen activator inhibitor 1 measurement	KDM4C UBR4 SNX8	1.80e-03	54	131	3	EFO_0004792
Disease	cryptococcosis	HLA-G PIAS1	1.98e-03	15	131	2	EFO_0007229
Disease	distal arthrogryposis (implicated_via_orthology)	MYH6 MYH7	1.98e-03	15	131	2	DOID:0050646 (implicated_via_orthology)
Disease	Malignant neoplasm of skin	CASP8 PTCH1 PTK2B	2.32e-03	59	131	3	C0007114
Disease	Skin Neoplasms	CASP8 PTCH1 PTK2B	2.32e-03	59	131	3	C0037286
Disease	hip bone mineral density	PTCH1 KCNH1 FGF14 DNAH11	2.45e-03	126	131	4	EFO_0007702
Disease	respiratory syncytial virus infectious disease (is_marker_for)	HLA-G TLR8	2.86e-03	18	131	2	DOID:1273 (is_marker_for)
Disease	Hereditary Non-Polyposis Colon Cancer Type 2	PALB2 ATM	3.18e-03	19	131	2	C1333991
Disease	Colorectal cancer, hereditary nonpolyposis, type 1	PALB2 ATM	3.18e-03	19	131	2	C2936783
Disease	brain measurement, neuroimaging measurement	PTCH1 CHMP7 CYRIA LATS1 FGF14 SSH2 SETD3 DNAH11	3.24e-03	550	131	8	EFO_0004346, EFO_0004464
Disease	thyroid stimulating hormone measurement	NEB DHX15 CYRIA KIAA1217 SNX8 ST18	3.27e-03	323	131	6	EFO_0004748
Disease	hypertension (biomarker_via_orthology)	MYH7 CASP8 ADCY5 PTK2B C3	3.50e-03	227	131	5	DOID:10763 (biomarker_via_orthology)
Disease	mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement	EFCAB6 FOCAD PTPRK VANGL1 EXOC7 SKA1	3.53e-03	328	131	6	EFO_0008377, EFO_0008378
Disease	Adenocarcinoma of prostate	PALB2 ATM	3.53e-03	20	131	2	C0007112
Disease	chemokine (C-C motif) ligand 27 measurement	STARD13 KDM4C NEK10	3.77e-03	70	131	3	EFO_0008082
Disease	polycystic ovary syndrome (biomarker_via_orthology)	PGR NCOR1	3.89e-03	21	131	2	DOID:11612 (biomarker_via_orthology)
Disease	BREAST CANCER	CASP8 ATM	3.89e-03	21	131	2	114480
Disease	Cleft palate	IARS1 PTCH1 CYRIA	3.92e-03	71	131	3	HP_0000175
Disease	neurodegenerative disease (implicated_via_orthology)	PTCH1 LATS1 RNF41 PNPLA7	4.05e-03	145	131	4	DOID:1289 (implicated_via_orthology)
Disease	Primary familial hypertrophic cardiomyopathy	MYH6 MYH7	4.26e-03	22	131	2	cv:C0949658

Protein segments in the cluster

Peptide	Gene	Start	Entry
QKYLRITRQQNYHSM	VANGL1	406	Q8TAA9
MRRCYSNQLVSDRYV	TDRD5	506	Q8NAT2
VSYMRENQQTFESYV	ALG13	266	Q9NP73
RNTVERMYRDTFSYN	APOBEC3G	6	Q9HC16
TQMSSRTLYINSRQL	ACSM2A	16	Q08AH3
LEANYMNLQRSYTVA	C3	1176	P01024
TVNEMSTRYYQNERR	DNAH11	3051	Q96DT5
NMGYVQQRRESSLKY	BUB3	166	O43684
DANTKYNSRAAQMYR	ARFGAP2	101	Q8N6H7
YNSRAAQMYREKIRQ	ARFGAP2	106	Q8N6H7
VRNQQYQEETYSRLM	ARHGEF15	511	O94989
YQEETYSRLMDTNVR	ARHGEF15	516	O94989
QRYFFRLNQSSLTML	ADCY5	231	O95622
YYAQRMIQYLSRRDS	AMBRA1	726	Q9C0C7
NYMNDSLRTNVFVRF	CCNL1	226	Q9UK58
YRSLMSADNVRQQLS	DHX15	651	O43143
QNISNLRDVFYREMS	BIN2	211	Q9UBW5
ASIVIQSTYRMYRQY	ASPM	2556	Q8IZT6
YITYRRASENMTQNT	DENND4A	141	Q7Z401
YRTQPMTAQAASYRA	RBM14	261	Q96PK6
QLTARRYQEKFTQYM	PDZRN4	186	Q6ZMN7
AYQYMLTDRENQSIL	MYH7	161	P12883
SQQTYYRVSNMDGRL	ABCD1	176	P33897
QTDRMNLQTLRGYYN	HLA-G	96	P17693
SYYRRTISRNRINNM	CYRIA	156	Q9H0Q0
QTARMRLSKYAAYNT	GREB1	1451	Q4ZG55
ELMSRHNIYVQAINY	ALAS1	546	P13196
SNYTVSSRQMLQEIR	LATS1	21	O95835
LYIQRTKSMFQRTTY	EIF3L	341	Q9Y262
MRVYNNTLTYGEVRN	GALNT9	456	Q9HCQ5
IRMYQVQYNSSVDDS	LRFN1	451	Q9P244
VQYNSSVDDSLVYRM	LRFN1	456	Q9P244
MTTEQRRSLQAFQDY	DDX58	1	O95786
SVYLDALNYRQMSGR	DDX60	1311	Q8IY21
YTNNQRYMAAIILSE	PLVAP	126	Q9BX97
RTQRYFMEANRNTVT	NEK10	811	Q6ZWH5
SFNSMLSRYYLTDLQ	NFE2L3	561	Q9Y4A8
IYSSMLYRQQESGRA	FGF14	156	Q92915
YSNFMASLNLRNRYA	PI4KA	1136	P42356
CFLSNRSRTYDMIQY	PI4KA	2081	P42356
RSRTYDMIQYYQNDI	PI4KA	2086	P42356
NTRYYSCRVMAVTSQ	KDM4C	891	Q9H3R0
YANTNRYHEMLNSVR	KCNH1	506	O95259
RQRIMDYYETNSQCS	CCL14	46	Q16627
VGALYSEERNYSQMR	PNPLA7	966	Q6ZV29
RNQDFMNVYYQIRSS	EXOC7	211	Q9UPT5
MNVYYQIRSSQLDRS	EXOC7	216	Q9UPT5
AEYYVRTTRSMSNCQ	PALB2	406	Q86YC2
VNLQYRRLYRSMNSQ	CTSA	366	P10619
RSQTQFEEMRSSYIR	PGR	836	P06401
VANMYSQIEKNYLRT	PCDH15	1896	Q96QU1
RNTVERMYRDTFSYN	APOBEC3F	6	Q8IUX4
ARFSDTQYQRIENYM	ATM	2391	Q13315
MITETAFRYQQELNY	ANKRD20A3P	566	Q5VUR7
QYFMTRSLENNRRNI	GRM6	341	O15303
QSLIKYMETQRSYTA	GIMAP2	241	Q9UG22
YMETQRSYTALAEAN	GIMAP2	246	Q9UG22
TITRNLQAFYNMLRS	EFCAB6	501	Q5THR3
RIYASQTDQMVFNAY	CHMP7	311	Q8WUX9
SNGRMRYTYQQRQDR	DNAJB12	221	Q9NXW2
EIQRRDSYYMTSSQL	IGHD	56	P01880
AQISAYRVMLYQISE	CASP8	96	Q14790
MFNAAYQSIQNYLRR	EDEM1	391	Q92611
NMFNRYSFDITNVVR	MANBA	121	O00462
TEIRQYFYRNMTAQN	MAN2B2	661	Q9Y2E5
MTAQNYTYAIRSRLT	MAN2B2	671	Q9Y2E5
RNATRYSVQLMSFVY	LAMP1	106	P11279
LVQLSMDFSSYYNRV	DALRD3	486	Q5D0E6
YTRRAMLAAIYNTTE	COQ9	241	O75208
AERFINYNQTVSRMR	EMC1	906	Q8N766
NYNQTVSRMRGIYTA	EMC1	911	Q8N766
RYRTTSSANNPNLMY	DDX17	566	Q92841
QQLRNDYMQRYASKV	PTK2B	156	Q14289
YAATLARNMELTYLN	CELSR3	2301	Q9NYQ7
LLESTMNEYYRQRNC	GRIK4	721	Q16099
TYRLTHQNMNSIEIY	C5orf34	341	Q96MH7
EMNLSQRVVSYQIRY	DHX37	321	Q8IY37
TLETRQMNRRYYENY	RNF41	261	Q9H4P4
QLIMTEQARRYLSTY	MYBL1	726	P10243
FQVMNSQQTISDRYY	CEBPZ	531	Q03701
ELMGYIRNVAYQSTS	FOCAD	1646	Q5VW36
SESNMDYTATIYLRQ	GABRP	76	O00591
YYRLSEMTEAEQQQL	CKMT1A	206	P12532
ESQRQGRISFYMTNY	BCKDHA	121	P12694
SSNYINAALMDSYRQ	PTPRK	1226	Q15262
RSMQNYVQFLKSSYA	ODF2	791	Q5BJF6
SSMFARNIYQLSFRQ	SLC5A7	356	Q9GZV3
RQTDFNLMRITYRFQ	SPEF2	146	Q9C093
DRQTEIYQYVLNSMA	STARD13	991	Q9Y3M8
MAYQLYRNTTLGNSL	GTF2A2	1	P52657
SQYEFENYMRQQLLL	STK40	371	Q8N2I9
YMKSRLTYNQINDVI	SKA1	151	Q96BD8
NAIQTMELRNYFSLY	SNX8	381	Q9Y5X2
ANNFARSFTLMLRYN	SYNE3	956	Q6ZMZ3
NDTAQFNRMTVEYVY	NKRF	456	O15226
SPQKSQRRYDMYNTA	SAMD9L	1181	Q8IVG5
SSFSEEQLNRYEMYR	TAF11	111	Q15544
IMQERASYVRSVYNL	PKDREJ	1986	Q9NTG1
NEESQMFYRRLSNLT	FASTKD3	96	Q14CZ7
YQLYAMENTRQTILN	NCOR1	1601	O75376
SALQASRVHVYMYNR	PTCH1	181	Q13635
LTSNMYQVRQRTLSY	SLC9A4	596	Q6AI14
SAAVNREYYRQQMEE	SETD3	481	Q86TU7
ISNMSLLRDSRNYSQ	KIAA1217	1246	Q5T5P2
AMATRTRQQYLQDLA	SIPA1	526	Q96FS4
TSQFYALNYSLRQRM	TELO2	596	Q9Y4R8
YSYNNFRVTSMQAVI	TENM1	2041	Q9UKZ4
MSYQSSSTEERRLNY	SEMG2	466	Q02383
YNNQCRAIVMRYSAE	IARS1	116	P41252
RNYSMAVYLVKQLSS	PIAS1	276	O75925
MTEDSQRNFRSVYYE	TBC1D7	1	Q9P0N9
AYQYMLTDRENQSIL	MYH6	161	P13533
TLAFQQARYNFIRSM	PI4KAP2	416	A4QPH2
QARYNFIRSMAAYSL	PI4KAP2	421	A4QPH2
CFLSNRSRTYNMIQY	PI4KAP2	571	A4QPH2
SRNRQFSYLIENMAR	MRPS2	146	Q9Y399
RYTRVTAMEYLNGQD	RPTOR	1066	Q8N122
AYVNTLTDMYSNLER	ST18	1011	O60284
SKMSLQLYQVDSRTY	PRKAA1	456	Q13131
TQMSSRTLYINSRQL	ACSM2B	16	Q68CK6
VATAVNTRQRYYPMA	RNF17	76	Q9BXT8
AMQTAERLYTQGYIS	TOP3B	321	O95985
VVLTENDSRYNNMYV	TLR8	1021	Q9NR97
RNLYRNVMLENYSNL	ZNF93	26	P35789
YRSVMLENYSNLVSL	ZNF268	106	Q14587
AQSRVYQLMEQDSYT	RGS18	176	Q9NS28
MLYYRSTSNNSELLS	TMEM143	341	Q96AN5
LESTYQNRTRYMVVV	SSH2	96	Q76I76
DSVMQQNLVYYRFHR	P3H4	326	Q92791
LQRYMDPSTYQVLSN	SLC35A4	106	Q96G79
HYQRDYSLIMQTLQE	TMCC1	486	O94876
TIGYNQRNRIDTLMY	POLR3B	696	Q9NW08
TSSRRYGQYTMNQES	ARHGAP18	36	Q8N392
QELRRQNYSSNAYHM	TSGA10	646	Q9BZW7
RNLYRNVMLENYSNL	ZNF626	26	Q68DY1
FGMYRCTIQLQSYRQ	SLC30A4	401	O14863
YSEMRNLATQRYGLV	WASHC4	751	Q2M389
YRNVMESNYETLVSL	ZNF212	166	Q9UDV6
YRNSSYENARENSQM	ZBTB38	581	Q8NAP3
SVLQRNIYSIYPMRN	VRTN	181	Q9H8Y1
SMLNSRNNFIRNYLS	UBR4	661	Q5T4S7
MVRTINLYYNNRTVQ	UBR4	3586	Q5T4S7
ALNSVAYERSAMQNY	TAC1	111	P20366
STQRSLYSDVMLENY	ZNF426	61	Q9BUY5
VMLENYRNLTSVEYQ	ZNF891	71	A8MT65
TQRRLYQDVMLENYS	ZNF81	41	P51508
AHQNLYREVMLENYS	ZFP69	96	Q49AA0
GYTTRDRNMNILQYC	KLHL42	351	Q9P2K6
LSTVVKYNSQYLNMR	KIAA1958	556	Q8N8K9
NSQALVSDMDYRNYL	NEB	4071	P20929